论文信息 - What's old is new again: the re-emergence of yellow fever in Brazil and vaccine shortages.

What's old is new again: the re-emergence of yellow fever in Brazil and vaccine shortages.

Yellow fever outbreaks have continued to occur and caused infection and deaths in travelers from non-endemic regions. Yellow fever vaccine has proven effective, but vaccination decision requires balancing its benefits with risks. Of concern is the continued vaccine shortage worldwide including the YF-VAX® stockout in North America that has presented many challenges.

P. Kozarsky | L. Visser | Lin H. Chen | Lin H Chen

[1] M. Turell,et al. History of Mosquitoborne Diseases in the United States and Implications for New Pathogens , 2018, Emerging infectious diseases.

[2] M. Cetron,et al. Fatal Yellow Fever in Travelers to Brazil, 2018 , 2018, MMWR. Morbidity and mortality weekly report.

[3] J. E. Staples,et al. Immunogenicity of Fractional-Dose Vaccine during a Yellow Fever Outbreak - Preliminary Report. , 2018, The New England journal of medicine.

[4] D. Hamer,et al. Vaccination Challenges in Confronting the Resurgent Threat From Yellow Fever. , 2017, JAMA.

[5] Yellow fever vaccine , 2017, Reactions Weekly.

[6] J. E. Staples,et al. Adverse event reports following yellow fever vaccination, 2007-13. , 2016, Journal of travel medicine.

[7] P. Sly,et al. The tolerability of a combined hepatitis A and typhoid vaccine in children aged 2-16 years: an observational study. , 2016, Journal of travel medicine.

[8] J. E. Staples,et al. Yellow Fever Vaccine Booster Doses: Recommendations of the Advisory Committee on Immunization Practices, 2015 , 2015, MMWR. Morbidity and mortality weekly report.

[9] Mary E. Wilson,et al. Vaccine administration decision making: the case of yellow fever vaccine. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10] K. Leder,et al. Aggregate travel vs. single trip assessment: arguments for cumulative risk analysis. , 2012, Vaccine.